Epigenetics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Epigenetics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

  • December 2021 •
  • 143 pages •
  • Report ID: 6197453 •
  • Format: PDF
The global epigenetics market exhibited strong growth during 2015-2020.

Looking forward, the analyst expects the market to grow at a CAGR of around 16% during 2021-2026.

Epigenetics refers to the study of heritable changes in the expression of active and inactive genes. The sources of changes can be both external from environmental factors or internal factors, such as age and disease. It is commonly used for the diagnosis of underlying conditions and preventing them from getting transferred to the future generations. It involves the use of various enzymes, instruments, such as sequencers, spectrometers and sonicators, reagents and kits. They are commonly utilized for deoxyribonucleic acid (DNA) and histone methylation, non-coding ribonucleic acid (RNA), acetylation and phosphorylation. As a result, epigenetics is widely used for the diagnosis, monitoring and treatment of oncological, autoimmune, metabolic, cardiovascular and pain disorders.

Epigenetics Market Trends:
The increasing prevalence of cancer and autoimmune deficiency syndrome (AIDS) across the globe is among the key factors driving the market growth. Moreover, the widespread adoption of epigenetic solutions for non-oncological ailments is providing a thrust to the market growth. The sudden outbreak of the coronavirus disease (COVID-19) is also providing growth opportunities to market players. For instance, various research institutes are running advanced epigenetic tests to study the impact of the virus on the human genome and are developing tools for early recognition, risk evaluations and developing personalized treatments. Additionally, the development of DNA and RNA modifying enzymes, such as acetylases, methyltransferases, reverse transcriptase and ligases, and the launch of highly sensitive and selective tests and instruments, are acting as other growth-inducing factors. These innovations facilitate the assessment of locus-specific DNA methylation on a genome. Other factors, including extensive research and development (R&D) activities in the field of biotechnology, along with significant improvements in the healthcare infrastructure, especially in the developing economies, are anticipated to drive the market toward growth.

Key Market Segmentation:
the analyst provides an analysis of the key trends in each sub-segment of the global epigenetics market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, product, technology and application.

Breakup by Product:
Chip Sequencing Kit
Whole Genomic Amplification Kit
Bisulfite Conversion Kit
RNA Sequencing Kit

Breakup by Technology:
DNA Methylation
Histone Methylation
Histone Acetylation
Large Non-Coding RNA
MicroRNA Modification
Chromatin Structures

Breakup by Application:
Solid Tumors
Liquid Tumors
Inflammatory Diseases
Metabolic Diseases
Infectious Diseases
Cardiovascular Diseases

Breakup by Region:
North America
United States
South Korea
United Kingdom
Latin America
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abcam plc, Active Motif Inc., Agilent Technologies Inc., Diagenode Diagnostics (Hologic Inc), Illumina Inc., Merck KGaA, PerkinElmer Inc., Roche Holding AG, Thermo Fisher Scientific Inc. and Zymo Research Corporation. Key Questions Answered in This Report:
How has the global epigenetics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global epigenetics market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the application?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global epigenetics market and who are the key players?
What is the degree of competition in the industry?